September 27, 2011
GREENWICH, CT and ANN ARBOR, MI – Biotronic, a Great Point Partners portfolio company, today announced the addition of Greg W. Sasso, as the Company’s Chief Executive Officer and President. Mr. Sasso joins Biotronic after a 26 year career at Biomet where he most recently was Senior Vice President and President of Biomet International, Biomet Sports Medicine and Biomet Microfixation which combined represented over $500 million in sales.
Mr. Sasso’s extensive experience encompasses driving both organic and acquisitive growth, including his leadership in Biomet’s acquisitions of Interpore, 3i and Bioelectron. Mr. Sasso was also one of the key members of the M&A team that led Biomet’s going-private transaction by a private equity consortium that consisted of Blackstone, Goldman Sachs, TPG and KKR for $11.7 Billion in 2007.
Bernie Kershner, Vice Chairman of Biotronic stated, “Biotronic has been experiencing rapid business growth both organic and acquisitive. As we expand our services and geographic footprint in intraoperative neuromonitoring, the time is right to add an admired and seasoned executive with global health care knowledge and exceptional leadership, sales and marketing expertise. We are honored to have Greg as our CEO.”
Mr. Sasso added, “Biotronic is committed to providing the highest quality intraoperative neurophysiological monitoring services in the United States and is poised for continued strong growth. I am excited to join the deep management team and clinical staff at Biotronic that have all contributed to its success thus far.”
Adam Dolder Managing Director of Great Point Partners and Chairman of the Company said, “We are thrilled to add Greg Sasso to the Biotronic team. Greg’s superior leadership skills, unparalleled industry successes and executive experience will prove to be an invaluable asset to Biotronic.”
Founded in 1978, Biotronic NeuroNetwork is headquartered in Ann Arbor, Michigan and currently employs over 225 administrative, support and clinical staff, including over 160 technicians throughout the country. Biotronic is the largest independent provider of intraoperative neurophysiological monitoring in the world, serving over 450 hospitals and 1,200 surgeons annually. www.biotronic.com
About Great Point Partners
GPP, based in Greenwich, CT, is a leading health care investment firm with approximately $450 million of equity capital under management. The firm manages capital in public (the Biomedical Value Fund) and private equity funds (GPP I – a $156 million private equity fund). Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 health care companies. The private equity fund invests in profitable companies across all sectors of the health care industry including behavioral health, biologics manufacturing, health care services, hospital outsourcing, information technology, life sciences, media and reagents, medical devices, specialty pharmaceuticals, and workers compensation. The firm pursues a proactive and proprietary approach to sourcing investments. Reach Great Point at 203-971-3300. www.gppfunds.com
This document is intended solely to provide information regarding Great Point Partners’ potential financing capabilities for prospective portfolio companies.